|
|
|
| home > white papers > Is Your Biobank Ready for the Challenge of Biomarker-based Research? - BioFortis |
|
|
 WHITE PAPERS |
|
|
BioFortis
|
|
Is Your Biobank Ready for the Challenge of Biomarker-based Research?
|
|
Targeted and personalized studies with well-defined patient segmentation biomarkers are becoming the norm in clinical trials. This increased interest in molecular biomarker studies necessitates a rigor and sophistication in sample management within the clinical trial context that is often not supported either by traditional clinical trial management software (CTMS), or biobanking systems. Download our Next Generation Biobanking whitepaper and learn about how to overcome the key challenges in clinical trial sample management from working in a distributed network of partners and stakeholder to managing consents and generating scientific insights.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Nemera reinforces its value proposition with a refreshing visual identity
At Nemera, we have been successfully providing high quality drug
delivery device solutions to our customers and patients for years. We
design and manufacture devices with the ultimate goal to improve patient
outcomes and experience.
More info >> |
|
 |
White Papers |
 |
|
Inhaler Adherence: Exploring Key Factors
Aptar Pharma
Aptar Pharma recently hosted an expert panel roundtable on “Inhaler Adherence”. This international scientific forum was held in Paris, France on November 29th 2013. The roundtable was organized to explore and exchange views on the issues which may influence inhaler adherence/ compliance with a particular focus on asthma and C.O.P.D. therapies and their corresponding inhaler devices (MDIs, DPIs).
More info >> |
|
|
|
